Multimedia

NAM IN THE NEWS: HON. JOHN P. DIBLASI, RICHARD P. BYRNE, ESQ. AND JACQUELINE SILVEY, ESQ. GO INSIDE THE MIND OF THE MEDIATOR AT THE NYCLA ADR COMMITTEE VIRTUAL MEETING

Posted on Nov 16, 2020

More than 40 invited guests as well as committee members had the honor of hearing three prestigious speakers from NAM (National Arbitration and Mediation) — the Hon. John P. DiBlasi, J.S.C. (Ret.), Richard P. Byrne, Esq., Commercial Law Specialist, and Jacqueline Silvey, Esq., General Counsel — discuss NAM's New York and national operations in the age of COVID.

CCBJ WEBCAST: RESOLVING COVERAGE DISPUTES IN MEDIATION

Posted on Oct 26, 2020

Join NAM award-winning neutral, Richard Byrne, Esq. to learn about the unique issues attendant to confronting and addressing insurance coverage disputes – with particular attention paid to the practical benefits of resolving these disputes via Mediation.

LAW.COM WEBCAST: ESTEEMED NAM PANEL PRESENTS “ARBITRATION AND MEDIATION IN THE WORKPLACE – IMPORTANT CONSIDERATIONS FOR AN ADR PROGRAM”

Posted on Oct 20, 2020

There are a number of important reasons why an employer might choose to implement a corporate employment ADR program in the workplace. Alternative dispute resolution (ADR) methods, such as arbitration and mediation, are often utilized to reduce the uncertainty and expenses of litigation, and can help reduce and resolve business and employment disputes. This esteemed panel will provide insight into the ADR process and how to address the creation and implementation of an employment ADR program.

VIDEO WEBCAST: VIRTUAL ADR UPDATE – TECHNOLOGY, CYBERSECURITY AND UNIQUE ISSUES PRESENTED BY HON. JOHN P. DIBLASI

Posted on Aug 05, 2020

Topics will include ethical issues and guidelines for both the participant and the mediator; ensuring security so as to preserve privacy and confidentiality; conducting the arbitration and mediation through the use of technology; conquering fears associated with its technical aspects, and the benefits of the technology for the ADR process in the face of COVID-19 and beyond.